Designed For Healthcare Providers
We go beyond the biotics—combining precision pre-, pro-, and postbiotics with targeted bioactives to maximize efficacy and support clinical outcomes
5+
Clinical Studies
15+
Exclusive Ingredients
20+
Global Patents
Order For Your Patients
Our products are designed to deliver targeted microbiome solutions that go beyond gut health to restore balance, address chronic struggles, and deliver precise clinical outcomes.
Advancing microbiome science with precision & innovation
Our precision microbiome solutions are backed by in vivo, in vitro, ex vivo, and clinical research, delivering targeted, long-term gut restoration through evidence-based, accessible interventions.
By harnessing the power of the Gut-X Axis—the next frontier in microbiome science—our targeted formulations optimize gut health and its critical connections to whole-body wellness.
Expect more from your microbiome ingredients
Our proprietary ingredients undergo extensive clinical research, delivering optimized prebiotics, probiotics, and postbiotics for targeted, long-term restoration and impact.
Explore Our Ingredients
Meet The Experts
Among the first to sequence precision-driven solutions, we harness cutting-edge technology to develop clinically studied prebiotic, probiotic, and postbiotic formulations. Backed by rigorous science, our innovations deliver measurable health benefits—designed for practitioners and trusted by patients.
C. Vivek Lal, MD, FAAP
Founder & CEO
Dr. Bindiya Gandhi, MD
Medical Ambassador
Amit Gaggar, MD, PhD
Chief Medical Officer
Kara Siedman, RD, CDCES
Director of Partnerships
Thea Nicola, Md, PhD, MBA
Director, Lab Operations
Namasivayam Ambalavanan, MD, FAAP
Pediatric Lung Disease
Endowed Professor & Virginia Walker Chair in Pediatrics, University of Alabama at Birmingham
Yvonne Huang, MD
Microbiome, Adult Lung Disease
Associate Professor, Pulmonary & Critical Care Medicine & Director Huang Microbiome Lab, University of Michigan
Nirmal Sharma, MD
Lung Transplant
Assistant Professor Medical Director Lung Transplantation Program, Brigham & Women’s, Harvard University
Kent Willis, MD, FAAP
Gut-Lung Axis, Mycobiome
Assistant Professor & Director, Willis Lung Lab, University of Alabama at Birmingham
Mike Wells, MD
Clinical Trials, Adult Lung Disease
Associate Professor, Pulmonary & Critical Care Medicine, University of Alabama at Birmingham
Casey Morrow, PhD
Microbiome
Professor Emeritus, Microbiome Resource Center & Cell Development & Integrative Biology, University of Alabama at Birmingham
Connect with an expert
Learn more about how to integrate our targeted microbiome solutions into your practice.
Schedule NowFor more support, contact us by emailing provider@resbiotic.com